Next Article in Journal
New Synthesized Activating Transcription Factor 3 Inducer SW20.1 Suppresses Resistin-Induced Metabolic Syndrome
Next Article in Special Issue
Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art
Previous Article in Journal
The Level of Intima-Media Thickness in Patients with Metabolic Syndrome in Poland Depending on the Prevalence of Type 2 Diabetes
 
 
Article

Article Versions Notes

Biomedicines 2023, 11(6), 1511; https://doi.org/10.3390/biomedicines11061511
Action Date Notes Link
article pdf uploaded. 23 May 2023 15:08 CEST Version of Record https://www.mdpi.com/2227-9059/11/6/1511/pdf-vor
article xml file uploaded 24 May 2023 05:20 CEST Original file -
article xml uploaded. 24 May 2023 05:20 CEST Update https://www.mdpi.com/2227-9059/11/6/1511/xml
article pdf uploaded. 24 May 2023 05:20 CEST Updated version of record https://www.mdpi.com/2227-9059/11/6/1511/pdf
article html file updated 24 May 2023 05:21 CEST Original file https://www.mdpi.com/2227-9059/11/6/1511/html
Back to TopTop